BCAX position history
The shares of Bicara Therapeutics (BCAX) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q4: 105,500 shares, $1.8M, 0.47% of portfolio, New
- 2025 Q1: 212,001 shares, $2.8M, 0.78% of portfolio, Add +100.9%
- 2025 Q2: 317,001 shares, $2.9M, 0.81% of portfolio, Add +49.5%
- 2025 Q3: 317,001 shares, $5M, 1.2% of portfolio
- 2025 Q4: 261,583 shares, $4.4M, 1.0% of portfolio, Reduce −17.5%
- 2026 Q1: 421,733 shares, $8.4M, 1.9% of portfolio, Add +61.2%
- 2026 Q2: 284,955 shares, $8.5M, 1.6% of portfolio, Reduce −32.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|